Percy H. Carter is CSO at Blueprint Medicines Corp (BPMC). They have made 9 open-market trades across 1 company since 2022, most recently 2025-07-17.
CIK 0001863024
Unrated. We grade insiders only on stock they chose to buy on the open market. Grants, option exercises and vesting say nothing about timing, so they don't count — which is why someone can file often and still have no grade. It isn't a bad sign: unrated buys beat every graded tier below A.
0 open-market purchases, against 9 sales. Too few scored purchases to measure a record yet.
| Ticker | Shares | Value |
|---|---|---|
| BPMC | 74,508 | $9.6M |
Shares reported on the most recent Form 4, priced at the 2025-07-21 close.
| Ticker | Type | Traded | Filed | Price | Value | 7d Stock | 30d Stock | 90d Stock |
|---|---|---|---|---|---|---|---|---|
| BPMC | SELL | 2025-07-03 | 2025-07-08 | $128.25 | $270K | +0.8% | N/A | N/A |
| BPMC | SELL | 2025-06-03 | 2025-06-05 | $127.88 | $649K | +0.1% | +0.3% | N/A |
| BPMC | SELL | 2025-03-05 | 2025-03-07 | $88.80 | $313K | +5.7% | -6.3% | +49.4% |
| BPMC | SELL | 2024-06-05 | 2024-06-07 | $105.13 | $421K | +2.7% | +13.6% | -10.7% |
| BPMC | SELL | 2024-06-03 | 2024-06-05 | $106.43 | $519K | -1.2% | +6.2% | -12.0% |
| BPMC | SELL | 2024-03-07 | 2024-03-11 | $90.69 | $415K | +1.0% | +1.5% | +16.7% |
| BPMC | SELL | 2023-06-05 | 2023-06-07 | $52.06 | $240K | +7.6% | +0.5% | -16.5% |
| BPMC | SELL | 2023-03-06 | 2023-03-08 | $45.69 | $35K | +3.2% | -3.4% | +32.1% |
| BPMC | SELL | 2022-06-06 | 2022-06-08 | $59.76 | $228K | -19.8% | -10.4% | +11.9% |
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.